Stock Taper
SCREENER COMPARE ANY 2 STOCKS
NVCR
NOVOCURE LTD
NASDAQ
$17.82
▼ DOWN 0.94% (-0.17)

KEY STATISTICS

Market Cap$2.08 B
52w High$21.45
52w Low$9.82
Dividend Yield—
Frequency—
P/E-13.71
Volume855.45K
Shares Out.116.45M

COMPANY

LEADERSHIP

Frank Leonard
CHIEF EXECUTIVE
Frank Leonard

ABOUT

SECTOR
Healthcare
WENT PUBLIC
October 2, 2015
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
1,605

PRICE TARGET

Target High$32.00
Target Low$20.00
Target Median$26.00
Target Consensus$26.00

UPCOMING EARNINGS

DateOct 29, 2026
DayThursday
Rev. Est.$182.28M
OCT
29
THU

PRICE

$17.82 ▼ DOWN 0.94% (−$0.17)
$17.40$17.60$17.80$18.009:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM17.82

About Novocure Ltd

https://www.novocure.com ↗

NovoCure Limited develops and commercializes tumor treating fields devices like Optune and Optune Lua for treating various solid tumor cancers worldwide, with ongoing trials in multiple cancer types.

INDUSTRY

Medical - Devices

A PRODUCT NOVOCURE LTD IS KNOWN FOR

Optune Lua
Optune Lua

Optune Lua is a portable device delivering Tumor Treating Fields to treat metastatic non-small cell lung cancer, offering a non-invasive, FDA-approved innovative therapy that disrupts cancer cell division.

COMPETITORS

COMPETITOR
BMY COMPARE
EXEL COMPARE
GILD COMPARE
MRK COMPARE
PFE COMPARE

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$96.61M $101.61M ▲$95.96M ▼$102.95M ▲
International Markets$65M $68.11M ▲$73.3M ▲$74.67M ▲
GERMANY$20.29M $21.33M ▲$24.5M ▲$23.34M ▼
FRANCE$19.62M $20.29M ▲$22.88M ▲$21.35M ▼
JAPAN$9.38M $10.21M ▲$10.24M ▲$11.78M ▲
CHINA$5.6M $4.63M ▼$4.79M ▲$5.96M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
166
LISTED HERE
26
RANKED BY POSITION SIZE
VTI
0.00% · 3.5M
XSU.TO
0.06% · 2.7M
SCHA
0.04% · 503.1K
DFAS
0.03% · 287.6K
FYC
0.31% · 250.7K
BR
BRNY
0.65% · 226.6K
R2SC.L
0.06% · 202.5K
NUSC
0.14% · 108.8K
PTH
0.68% · 106.7K
XRSU.L
0.06% · 97.9K
ITEQ
1.21% · 77.3K
GSSC
0.12% · 74.4K
HTEC
1.40% · 60.7K
RSSL
0.06% · 51.1K
ONEQ
0.01% · 49.5K
ISRA
0.53% · 48.3K
VALT
1.43% · 45.0K
BBSC
0.07% · 30.0K
FSML
0.23% · 19.3K
DTN
0.27% · 16.7K
URTY
0.02% · 4.3K
RFLR
0.08% · 4.2K
DTAN
0.27% · 3.4K
ACSG
0.10% · 3.0K
TILT
0.00% · 2.8K
BUYO
0.28% · 2.6K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
73.66%
HOLDERS
405
TOP 12 OF 405 · RANKED BY POSITION SIZE
Fmr LLC
17.4M sh · $263.2M
Blackrock, Inc.
13.9M sh · $180.2M
Blackrock Inc.
12.1M sh · $207.83M
Vanguard Group Inc
11.0M sh · $141.69M
Soleus Capital Management, L.P.
10.5M sh · $114.37M
Morgan Stanley
5.1M sh · $65.55M
Wells Fargo & Company/Mn
3.0M sh · $32.17M
State Street Corp
2.9M sh · $43.43M
Geode Capital Management, LLC
2.8M sh · $42.4M
Blackrock Fund Advisors
2.7M sh · $21.13M
Quantinno Capital Management LP
2.5M sh · $27.11M
Capital World Investors
2.0M sh · $25.84M

RATINGS SNAPSHOT

Overall rating: D+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book2
Overall Score1

TRADES BY CONGRESS

HOUSE TRADES
Ro Khanna
Ro Khanna
Purchase
2022-02-14
 Marie Newman
Marie Newman
Purchase
2021-07-02
 Donna Shalala
Donna Shalala
Sale (Full)
2019-06-24

INSIDER TRADES

★
OFFICER: GENERAL COUNSEL
Ben Arye Barak
Purchase · 1.3K shares
2026-06-30
★
DIRECTOR
Danziger Asaf
Purchase · 268 shares
2026-06-30
★
OFFICER: CHIEF HUMAN RESOURCES OFFICER
Puri Michal Nath
Purchase · 1.9K shares
2026-06-30
★
OFFICER: CHIEF EXECUTIVE OFFICER
Leonard Frank X
Purchase · 1.9K shares
2026-06-30

MOST RECENT ANALYST GRADES

GRADE SUMMARY
NEUTRAL 2
BUY 1
EQUAL WEIGHT 1
OUTPERFORM 1
5 GRADES IN THE LAST 12 MONTHS
Wedbush NEUTRAL HC Wainwright & Co. BUY Wells Fargo EQUAL WEIGHT Evercore ISI Group OUTPERFORM JP Morgan NEUTRAL

SECTORS PEERS

PEERPRICE
PLSE$47.57COMPARE
NEOG$11.66COMPARE
ESTA$70.64COMPARE
BLFS$36.38COMPARE
AZTA$32.95COMPARE
KMTS$25.64COMPARE
TDOC$6.50COMPARE
STAA$22.11COMPARE